Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 21, 2016 – The FDA approved new updates to the Warnings and Precautions and Limitations of Use sections of the Zydelig (idelalisib) drug label.
Return to publications